Biotech companies at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
34 biotech companies are at SCOPE 2027 — 47 presentations on the program and 2 with a booth in the exhibit hall. Most represented: Genmab (4 on the program), Keenova Therapeutics (4 on the program), BeOne Medicines (3 on the program). 17 of them have their own page in this guide. As of Oct 17, 2026.
Topic
Top represented
Showing 1–15 of 34 organizations
| Organization | SCOPE 2027 Attendance |
|---|---|
Genmab Copenhagen, Denmark | |
Danish antibody company with marketed cancer medicines, including Epkinly and Tivdak, and royalties on Darzalex. | Talk Tue Mar 2 12:20pm–12:45pm Panel Tue Mar 2 4:45pm–5:10pm |
Specialty therapeutics company marketing medicines in immunology, urology, orthopedics, critical care and pediatric endocrinology. | Talk Wed Mar 3 11:40am–12:30pm Talk Wed Mar 3 3:00pm–3:50pm Back to the Future: The AI Workforce—Then, Now, and Next AI in clinical research |
Global oncology company, formerly BeiGene, developing and marketing cancer medicines. | Talk Tue Mar 2 12:20pm–12:45pm Panel Wed Mar 3 3:25pm–3:50pm From Data Noise to Decision: Making RBQM Work at Scale Quality, monitoring and safety Panel Thu Mar 4 9:25am–9:50am |
Alnylam Pharmaceuticals Cambridge, MA | |
Develops and markets RNA interference medicines for rare and common diseases. | Panel Tue Mar 2 3:20pm–3:55pm Talk Wed Mar 3 11:40am–12:05pm Scaling Operations and Talent for Phase 3 and Beyond Outsourcing and budgeting |
BioNTech Mainz, Germany | |
Develops mRNA vaccines and cancer immunotherapies. | Talk Tue Mar 2 11:05am–11:30am Talk Tue Mar 2 3:30pm–3:55pm |
Kymera Therapeutics Watertown, MA | |
Biotechnology company developing oral protein degrader medicines for immune and inflammatory diseases. | Talk Tue Mar 2 12:20pm–12:45pm Panel Tue Mar 2 12:20pm–12:45pm |
Compass Pathways London, United Kingdom | |
Develops a psilocybin treatment for treatment-resistant depression. | Panel Tue Mar 2 12:20pm–12:45pm Trial Oversight and Governance in Lean ClinOps Environments Quality, monitoring and safetyOutsourcing and budgeting Talk Wed Mar 3 2:35pm–3:00pm Panel Wed Mar 3 3:25pm–3:50pm |
Develops cancer therapies, with approved medicines in China and clinical programs worldwide. | Talk Wed Mar 3 9:25am–9:50am Panel Wed Mar 3 12:05pm–12:30pm |
AskBio Research Triangle Park, NC | |
Gene therapy company owned by Bayer, developing AAV-based treatments. | Talk Tue Mar 2 11:30am–11:55am Lean by Design, Backed by Scale: Clinical Operations in a Subsidiary Model Outsourcing and budgeting Panel Wed Mar 3 3:25pm–3:50pm From Early-Stage Success to Global Phase 3 Execution: How Biotechs Can Build the People, Processes, Technology, and Governance to Scale Trial design and deliveryOutsourcing and budgeting |
BlueRock Therapeutics Cambridge, MA | |
Bayer-owned cell therapy company developing stem cell-derived treatments for neurological and other diseases. | Panel Mon Mar 1 4:13pm–4:35pm KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards Patient recruitment and engagement Talk Tue Mar 2 3:05pm–3:30pm Creating More Time to Think: The Necessity of Agile Operational Dashboards Clinical data and real-world evidence |
Cognition Therapeutics Purchase, NY | |
Develops small-molecule drugs for neurodegenerative diseases such as Alzheimer's disease and dementia with Lewy bodies. | Talk Tue Mar 2 11:05am–11:30am Why Can’t We Solve Underrepresentation in Our Clinical Trials? Patient recruitment and engagement Panel Tue Mar 2 12:20pm–12:45pm Trial Oversight and Governance in Lean ClinOps Environments Quality, monitoring and safetyOutsourcing and budgeting |
Contraline Charlottesville, VA | |
Develops reversible male contraceptives, including a long-acting implant and a daily gel, both in clinical testing. | Talk Tue Mar 2 3:30pm–3:55pm Panel Tue Mar 2 4:45pm–5:10pm |
Develops Trappsol Cyclo, a cyclodextrin-based treatment for Niemann-Pick disease type C. | Panel Tue Mar 2 12:20pm–12:45pm Trial Oversight and Governance in Lean ClinOps Environments Quality, monitoring and safetyOutsourcing and budgeting Talk Wed Mar 3 2:35pm–3:00pm Bigger, Faster, Leaner: Operational Blueprints for Global Clinical Scale-Up Trial design and deliveryOutsourcing and budgeting |
4D Molecular Therapeutics Emeryville, CA | |
Clinical-stage gene therapy company developing AAV-based treatments for eye and lung diseases. | Talk Wed Mar 3 9:20am–9:35am How to Streamline Monitoring Report Reviews with AI AI in clinical researchQuality, monitoring and safety |
AT AlphaRose Therapeutics | |
Talk Tue Mar 2 8:40am–9:05am The Other Side of Drug Development: Pharma Leader's Journey as a Rare Disease Parent Patient recruitment and engagement |
Instantly find 20 buyers from biotech companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse SCOPE 2027 by
Organization type
Topic
- Trial design and delivery 116
- Site strategy and partnering 99
- Patient recruitment and engagement 96
- Clinical data and real-world evidence 122
- AI in clinical research 79
- Digital measures and eClinical technology 83
- Clinical supply and logistics 39
- Quality, monitoring and safety 72
- Outsourcing and budgeting 71
- Biospecimen strategy and operations 35
Exhibit hall
Everyone
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction